147 related articles for article (PubMed ID: 2918948)
1. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
Yoshizawa N; Kusumi Y; Matsumoto K; Oshima S; Takeuchi A; Kawamura O; Kubota T; Kondo S; Niwa H
Nephron; 1989; 51(3):370-6. PubMed ID: 2918948
[TBL] [Abstract][Full Text] [Related]
2. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
[TBL] [Abstract][Full Text] [Related]
3. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats.
Tanaka R; Yoshikawa N; Nakamura H; Ito H
Nephron; 1992; 60(1):35-41. PubMed ID: 1738411
[TBL] [Abstract][Full Text] [Related]
4. Loss of glomerular polyanion in vitro induced by mononuclear blood cells from patients with minimal-change nephrotic syndrome.
Bakker WW; van Luijk WH; Hené RJ; Desmit EM; van der Hem GK; Vos JT
Am J Nephrol; 1986; 6(2):107-11. PubMed ID: 2422934
[TBL] [Abstract][Full Text] [Related]
5. Effect of prednisone on nephrotic peripheral blood mononuclear cell mediated increase in 35sulfate uptake in rat glomerular basement membrane.
Garin EH
Nephron; 1989; 53(3):268-72. PubMed ID: 2797347
[TBL] [Abstract][Full Text] [Related]
6. Effect of concanavalin A on nephrotic peripheral blood mononuclear cells mediated increased 35sulfate uptake in rat glomerular basement membrane.
Garin EH; Boggs KP
Pediatr Res; 1986 Apr; 20(4):321-3. PubMed ID: 3703621
[TBL] [Abstract][Full Text] [Related]
7. An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.
Fujiwara Y
Virchows Arch A Pathol Anat Histopathol; 1984; 405(1):11-24. PubMed ID: 6438895
[TBL] [Abstract][Full Text] [Related]
8. A glomerular permeability factor produced by human T cell hybridomas.
Koyama A; Fujisaki M; Kobayashi M; Igarashi M; Narita M
Kidney Int; 1991 Sep; 40(3):453-60. PubMed ID: 1787645
[TBL] [Abstract][Full Text] [Related]
9. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
10. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
[TBL] [Abstract][Full Text] [Related]
13. Effect of peripheral blood mononuclear cells from patients with nephrotic syndrome on uptake of 35sulfate by glomerular basement membrane.
Garin EH; Boggs KP
Int J Pediatr Nephrol; 1985; 6(3):189-94. PubMed ID: 4055237
[TBL] [Abstract][Full Text] [Related]
14. Minimal change nephrotic syndrome and prohibitin-2 gene polymorphism.
Sugimoto K; Miyazawa T; Miyazaki K; Yanagida H; Enya T; Nishi H; Wada N; Okada M; Takemura T
Clin Exp Nephrol; 2017 Aug; 21(4):665-670. PubMed ID: 27812762
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural alteration of glomerular anionic sites in nephrotic patients.
Washizawa K; Kasai S; Mori T; Komiyama A; Shigematsu H
Pediatr Nephrol; 1993 Feb; 7(1):1-5. PubMed ID: 7679919
[TBL] [Abstract][Full Text] [Related]
16. Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome.
Tomizawa S; Maruyama K; Nagasawa N; Suzuki S; Kuroume T
Nephron; 1985; 41(2):157-60. PubMed ID: 3876517
[TBL] [Abstract][Full Text] [Related]
17. Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries.
Maruyama K; Tomizawa S; Shimabukuro N; Fukuda T; Johshita T; Kuroume T
Nephron; 1989; 51(1):73-6. PubMed ID: 2783765
[TBL] [Abstract][Full Text] [Related]
18. [The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism].
Watanabe Y; Suzui J; Ichikawa Y; Yoshida K; Suzuki H
Arerugi; 1995 May; 44(5):547-55. PubMed ID: 7619008
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.
González E; Neuhaus T; Kemper MJ; Girardin E
Nephrol Dial Transplant; 2009 Jan; 24(1):149-55. PubMed ID: 18697798
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
